# PAM Financial Systems — Pilot 001 workflow v0.2 closure and bounded follow-up Work Order

**Record date:** 2026-10-27 (Toronto local)  
**Research RUN_ID:** `PAM-RESEARCH-20261027-002`  
**Pilot Work Order:** `WO-FIN-REFORM-3PROJECT-POC`  
**CEO decision:** 2026-10-27, CEO answered “go” to PM's proposal to accept **limited closure** of Pilot 001 v0.2 and prepare one targeted read-only gap-review mandate.  
**Status of pilot:** `CLOSED — MANUAL TRANSPORT DEMONSTRATED / RESEARCH NOT READY`  
**Status of this GitHub record:** `PROPOSED_IN_PR — NOT CANONICAL UNTIL SEPARATE CEO MERGE`  
**No private holdings, account numbers, screenshots or tax information are contained here.**

## A. Decision-grade boundaries and observed result

**Accepted limited conclusion:** one CEO-carried `CC → IR → PI → CC` regression was completed as an exploratory workflow test. Three manual transfers were manifested and one targeted IR evidence-portability repair was reported. The repair added the missing provenance for K01 (F14) and full-text URL locators for S00–S10. PI supplied only `PI_DELTA` and appropriately declined to infer holdings, portfolio room, allocation percentages, fees or net performance without any portfolio evidence. CC produced an end report. The original Pilot 001 baseline and human effort for either pilot were not measured, so a quantitative improvement relative to v0.1 is **not demonstrated**.

**Independently checked in PM's current conversation container:** the two text handoff files generated for T02 and T03 carried identical literal IR content **between** `# FORWARD_UNCHANGED — BEGIN` and `# FORWARD_UNCHANGED — END`, after UTF-8 read and LF newline normalization. Each inner body was 38,919 characters / 517 split lines, with SHA-256 `047c27b1abe7836e5f4cfb53997eb6cd8082102b28819d9a6b7aeb4baccf18cd`. The enclosing delimiters and blank lines account for differing inclusive line counts reported by other readers (520). This only proves identity of the **two available copies**, not external-source authenticity or historic PIT availability. Their two full prompt files were 562 and 595 lines respectively; T03 was 48,263 characters as read locally.

**PI's reported input completeness:** 11 S source records including S07 index-only/HTTP 403; F01–F14 (14); K01–K08 (8; K08 NOT_COMPUTED); V01–V06 (6). IR reported use of a deterministic calculator; CC reported selective primary-source corroboration and independent arithmetic checks. These source-read and calculator-use assertions were not wholly re-enacted by PM, and are not elevated here to independent certification.

**Financial status:** `EXPLORATORY / PIT_UNVERIFIED / METHOD_NOT_LOADED / PACKET_INCOMPLETE`; entry prices synchronized to the frozen 2026-10-27 16:29 EDT information cutoff were unavailable (`F12`); relative 5–10-year issuer/VFV Expected Return could not be defensibly computed (`K08`). A qualitative IR view favored Amphenol on Quality/Durability and Celestica on growth optionality; neither establishes a buy recommendation, return superiority to VFV, position suitability, or approved portfolio allocation. No real private holdings were provided or accessed; numerical `PORTFOLIO ROOM = UNAVAILABLE`.

**Readiness outcomes:** `MANUAL_EVIDENCE_TRANSPORT = PASS (bounded copies)`; `RESEARCH-READY = NOT ACCEPTED`; `PORTFOLIO-READY = NOT ACCEPTED`; `ROUTINE-READY = NOT ACCEPTED`. This is not V1 replacement, V2 promotion, production, deployment, trading, authentic PIT, licensed-data approval, or autonomous collaboration authority.

**Observed human work:** the exact number of human minutes was `NOT_RECORDED`. Three manual transfers plus one repair cycle were documented. No claim is made that the ~1-hour/week operational target has been attained. External financial-data cost of `$0` was **reported** within the pilot; billing/rights were not independently audited by this document.

## B. First read-only GitHub inventory — already-existing elements

PM inspected live `model-v2/expected-return-challenger` on 2026-10-27 at base commit `440cb933728098e36d216e448477d7e459d93210`. The recursive source tree was not truncated (824 entries); targeted documents were read. **This is a scoped first-pass inventory, not an exhaustive method/access review.**

| Existing file/contract | What it already provides | Important boundary to preserve |
|---|---|---|
| `docs/contracts/v2/expected_return/COMPANY_VFV_EXPECTED_RETURN_COMPARATOR.md` | Named/versioned company-versus-VFV diagnostic and normalized EPS/cashflow IRR method reference | Requires narrowly admitted PR5E company evidence plus VFV forward evidence; no general AI issuer-research method, recommendation or portfolio authority |
| `docs/contracts/v2/expected_return/EXPECTED_RETURN_PR5E.md` | Versioned real-evidence admission route and fail-closed statuses | Only one bounded ordinary-compounder/nonpayer route; V2 diagnostic challenger, not broad issuer coverage |
| `docs/contracts/v2/expected_return/VFV_FORWARD_EXPECTED_RETURN.md` | Standalone named VFV method and explicit policy/math | Not a generic ETF model nor an automatic company-comparator method |
| `docs/contracts/v2/durability/QUALITATIVE_DURABILITY_RESEARCH_NOTE_V1.md` | Qualitative research-note structure with sources, competing explanations and operator caveats | Manual, current-capture only, no native evidence-admission or verified historical truth |
| `docs/contracts/v2/durability/UNIFIED_PRIVATE_DURABILITY_RESEARCH_SHEET_V1.md` | Presentation of D1/D2 diagnostics plus qualitative note | Private research presentation only; cannot certify source truth or independent PIT |
| `docs/contracts/v2/foundation/PIT_COMPARISON_PR3.md` | Immutable retrospective comparison infrastructure and SHA/source export controls | Diagnostic workflow, not automatic authentic historical market/issuer-data admission |
| `docs/contracts/v2/expected_return/EXPLICIT_UNSUPPORTED_CASE_HANDLING.md` | Explicit unavailable/unsupported/conflict semantics | Not an estimating fallback or portfolio decision layer |
| `docs/contracts/v2/research/CURRENT_ANNUAL_REPORTED_FACT_RESEARCH_CANDIDATE.md` | Research-candidate evidence identity/semantics | Explicitly design-reference-only, not implemented and no runtime authority |

**Important distinction:** Pilot IR's `METHOD_NOT_LOADED` is truthful about the specialist's *actually loaded method*. It does **not** mean GitHub contains no methods. Existing scoped V2 policy or contract IDs must not be silently repurposed into a newly approved general IR Project method or investment policy.

## C. ONE follow-up Work Order — proposal for attended specialist handoff

**WORK ORDER:** `WO-FIN-AI-NATIVE-POST-PILOT001-V02-GAP-DIAGNOSTIC`  
**FROM:** PAM organizational Program Manager  
**TO / SINGLE PRIMARY ROLE:** **Architecture & Audit**  
**STATUS:** `CEO_AUTHORIZED_TO_PREPARE / HANDOFF_NOT_YET_EXECUTED`  
**TASK COMPLEXITY:** `MEDIUM`  
**OUTPUT BUDGET:** `STANDARD` (decision-first, normally <= ~1,500 words plus compact source map)  
**REPO CHANGE EXPECTED:** `NO` from the specialist; this closure/WO publication itself is an independent CEO-merge-gated documentation PR.

### Objective

Provide one bounded, read-only diagnostic identifying the **smallest credible next research validation** after v0.2 Pilot 001; do not implement a new system. Assess the three linked gaps **in order**:

1. **Method actually available:** trace authoritative existing quality/durability/expected-return sources, named versions, applicability and status across GitHub; separate valid limited V2 contracts from a possible short, CEO-approvable AI-native `Investment Research` analytical method. State `REUSE_AS_IS / ADAPT_WITH_EXPLICIT_APPROVAL / GAP`; do not claim any unavailable method was loaded during the pilot.
2. **Financial source and PIT testability:** specify the minimum rights-permitted, $0-cost, actually available evidence needed for one date-frozen CLS.TO/APH/VFV replay and for ordinary *current* research. Distinguish dated filings from captured historic snapshots, original quote evidence from dynamic pages, and partial/unsupported cases. Identify what F12/K08 would need; do not replace accuracy controls with guessed prices or build an entire PIT engine.
3. **Compact and measurable transfer:** propose the smallest safe alternative to recurring ~48 KB copy/paste packets (e.g. accessible evidence index and content hashes with complete material locators/statuses), **but** require an explicit recipient-access test and exact semantic/fidelity check before dropping the full `FORWARD_UNCHANGED` fallback. Define human start/stop time measurement across attended hops and repairs. No untested cross-Project API, GitHub private-file access or background automation promises.

### Why now

The previous regression proved bounded manual carriage but revealed a missing specialist method, incomplete point-in-time/price inputs, cumbersome copy size and unmeasured CEO labor. Duplicative software work would risk rebuilding already-existing V2 capabilities without increasing research truth.

### Mandatory sources and constraints

Read in canonical order: `PAM_PROJECT_CONSTITUTION.md`, `governance/PAM_GOVERNANCE.md`, `governance/PAM_CURRENT_STATE.md`, `governance/roles/ARCHITECTURE_AUDIT.md`, **this Work Order**, `governance/PAM_STRATEGY.md` and `AGENTS.md`. Then inspect only applicable contracts listed in §B, the three `docs/ai_native/project_instructions/*.md` documents and the CEO-supplied Pilot 001 final report when provided. This GitHub summary is not a substitute for the complete private-chat evidence packet; do not presume it is otherwise accessible.

Use live branch/head and cite exact paths + version IDs. Consult Data & Evidence or Product & UX only if a narrowly defined material question cannot be answered from available facts; report any actual consultation rather than inventing an agent invocation.

### Authority

CEO authorized limited pilot closure and preparation of this bounded diagnostic. Attended **read-only** repository/document review and compact findings are permitted. PM may arrange a manually copied specialist handoff. No additional owner approvals are needed for read-only checks within this scope.

### Prohibited

No repository mutation by specialist, coding, CI, data subscription or spending, account/Blossom access, broker action, autonomous agent delegation, scheduled/unattended work, model/policy changes, invented historic quotes, source admission or PIT authority, migration, publication of private portfolio data, device cleanup, or protected amendment. Existing V1 `main` frozen authority and V2 challenger/Stage D restrictions remain. Any subsequent prompt version, new source route, implementation, production change or canonical merge requires separate CEO approval.

### Deliverable and acceptance

Return one `ARCHITECTURE & AUDIT` handoff with:
- Evidence-backed **method reuse matrix** and exact claimed authority/version, identifying whether the specialist method is *not loaded*, *absent*, or merely *limited in scope*;
- Minimal PIT/source test design with success/fail-closed cases, dated source and quote rights/availability caveats, without implementation;
- One compact-transfer experiment design with hash, recipient retrieval, evidence-status preservation, failure/fallback and human effort metrics;
- A **single recommended next execution sequence**, smallest next CEO decision, blockers, risks, validation criteria and `RESEARCH-READY` gate not yet accepted;
- Repo change `NONE`; status `DIAGNOSTIC_ONLY`.

**STOP after the diagnostic.** Do not send any autonomous Codex task or assume the next implementation has been authorized.

## D. Institutional-memory boundaries

This public GitHub document contains operational method/transfer lessons and public document paths only. The original financial source packets and any account-specific evidence remain outside this PR. This pilot record is not an immutable original evidence archive and is not an approval of a reusable investment methodology. Retain the manual provenance/versions and, if later creating a versioned history case, apply separate privacy, source-rights and CEO review controls.
